A detailed history of Frazier Financial Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 13 shares of VRTX stock, worth $6,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 23 43.48%
Holding current value
$6,002
Previous $10.8 Million 43.91%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$460.0 - $505.78 $4,600 - $5,057
-10 Reduced 43.48%
13 $6.05 Million
Q2 2024

Aug 12, 2024

SELL
$392.81 - $485.53 $1,571 - $1,942
-4 Reduced 14.81%
23 $10.8 Million
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $5,707 - $6,245
14 Added 107.69%
27 $11.3 Million
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $4,459 - $5,338
13 New
13 $5.29 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.